Abbott Laboratories (NYSE:ABT)
| 127.70 Delayed Data As of Oct 27 |  -0.01 / -0.01%Today’s Change | 103.13 Today|||52-Week Range 129.70 | +16.63% Year-to-Date |
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 127.71 |
| Today’s open | 128.77 |
| Day’s range | 127.37 - 128.89 |
| Volume | 515 |
| Average volume (3 months) | 4,892,740 |
| Market cap | $224.7B |
Data as of 4:27pm ET, 10/27/2021
Growth & Valuation
| Earnings growth (last year) | +21.67% |
| Earnings growth (this year) | +36.53% |
| Earnings growth (next 5 years) | +12.70% |
| Revenue growth (last year) | +8.48% |
| P/E ratio | 36.0 |
| Price/Sales | 5.65 |
| Price/Book | 6.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -1.35 | -0.55% |
| BSXBoston Scientific Co... | -0.59 | -1.33% |
| DXCMDexcom Inc | -7.10 | -1.26% |
| BAXBaxter International... | +0.15 | +0.18% |
Data as of 4:01pm ET, 10/27/2021
Financials
| Next reporting date | January 26, 2022 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $34.6B |
| Annual profit (last year) | $4.5B |
| Net profit margin | 12.86% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
